107 related articles for article (PubMed ID: 15674425)
1. Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells.
Farahani M; Treweeke AT; Toh CH; Till KJ; Harris RJ; Cawley JC; Zuzel M; Chen H
Leukemia; 2005 Apr; 19(4):524-30. PubMed ID: 15674425
[TBL] [Abstract][Full Text] [Related]
2. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
3. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
4. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand in CLL pathogenesis and therapy.
Schattner EJ
Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
[TBL] [Abstract][Full Text] [Related]
6. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
7. Survival of chronic lymphocytic leukemia cells: CD40L and the vascular endothelial growth factor (VEGF) connection.
Kay NE; Wasil T
Leukemia; 2005 Apr; 19(4):531-2. PubMed ID: 15861177
[No Abstract] [Full Text] [Related]
8. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia.
Schillaci R; Galeano A; Becu-Villalobos D; Spinelli O; Sapia S; Bezares RF
Br J Haematol; 2005 Jul; 130(1):58-66. PubMed ID: 15982345
[TBL] [Abstract][Full Text] [Related]
9. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
[TBL] [Abstract][Full Text] [Related]
10. All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
Bairey O; Boycov O; Kaganovsky E; Zimra Y; Shaklai M; Rabizadeh E
Leuk Res; 2004 Mar; 28(3):243-8. PubMed ID: 14687619
[TBL] [Abstract][Full Text] [Related]
11. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
12. A sustained activation of PI3K/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells.
Cuní S; Pérez-Aciego P; Pérez-Chacón G; Vargas JA; Sánchez A; Martín-Saavedra FM; Ballester S; García-Marco J; Jordá J; Durántez A
Leukemia; 2004 Aug; 18(8):1391-400. PubMed ID: 15175625
[TBL] [Abstract][Full Text] [Related]
13. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
[TBL] [Abstract][Full Text] [Related]
15. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.
Pedersen IM; Kitada S; Leoni LM; Zapata JM; Karras JG; Tsukada N; Kipps TJ; Choi YS; Bennett F; Reed JC
Blood; 2002 Sep; 100(5):1795-801. PubMed ID: 12176902
[TBL] [Abstract][Full Text] [Related]
16. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
[TBL] [Abstract][Full Text] [Related]
17. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
Poggi A; Prevosto C; Catellani S; Rocco I; Garuti A; Zocchi MR
Br J Haematol; 2010 Nov; 151(3):252-64. PubMed ID: 20813004
[TBL] [Abstract][Full Text] [Related]
18. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
Lapalombella R; Andritsos L; Liu Q; May SE; Browning R; Pham LV; Blum KA; Blum W; Ramanunni A; Raymond CA; Smith LL; Lehman A; Mo X; Jarjoura D; Chen CS; Ford R; Rader C; Muthusamy N; Johnson AJ; Byrd JC
Blood; 2010 Apr; 115(13):2619-29. PubMed ID: 19965642
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
[TBL] [Abstract][Full Text] [Related]
20. Increased autocrine interleukin-6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia.
Wang HQ; Jia L; Li YT; Farren T; Agrawal SG; Liu FT
J Cell Physiol; 2019 Aug; 234(8):13994-14006. PubMed ID: 30623437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
